MB Therapeutics deploys 3D printing technology at Angers university hospital
Discover how medical 3D printing is being integrated at the CHU d’Angers. Expert support, commissioning, and the challenges of tomorrow’s medicine.
French-German cooperation: MB Therapeutics welcomes the Saxony delegation!
A look back at the visit of a delegation from Saxony to MB Therapeutics. A moment of exchange to showcase our pharmaceutical expertise to our German partners.
MB Therapeutics: Putting CSR at the heart of innovation with Med-Transitions
Discover how MB Therapeutics integrates CSR into every strategic decision, from 3D drug printing to sustainable office management.
3D printing of medicines: MB Therapeutics at the BioTrace congress
Discover 3D printing of medications and how it is transforming pharmaceutical production, particularly with 3DforPedia.
MB Therapeutics: 3D printing at the heart of regional innovation
Focus on 3D printing: MB Therapeutics welcomes long-standing partners University of Montpellier, Nîmes University Hospital, and the Occitanie Region.
MB Therapeutics awarded France 2030 project grant: accelerating innovation in healthcare
€500,000 to industrialize our pharmaceutical inks and equip the first pilot pharmacies by 2026. Discover how this strategic support will accelerate our deployment.
MB Therapeutics strengthens its growth strategy with the appointment of a Chief Business Officer
Meet our Chief Business Officer, appointed to accelerate our commercial development and expand our model internationally.
MB Therapeutics at the heart of innovation at SantExpo 2025
MB Therapeutics is one of the startups highlighted at SantExpo 2025 alongside the University of Montpellier’s Innovation Hub (PUI).
MB Therapeutics: a company committed to 360° CSR
MB Therapeutics redesigns its offices with Les Simones, combining sustainable design, second-hand furniture, and a strong local CSR commitment.
New quality expertise at the heart of MB Therapeutics
MB Therapeutics welcomes its responsible pharmacist and CQO to strengthen its production of GMP-certified pharmaceutical inks.
A step further towards pharmaceutical innovation in 3D
MB Therapeutics has settled into its new premises. New address, same tight-knit team, and even more energy!
A week of pharmaceutical innovation for MB Therapeutics
From Rotterdam to Lyon… The MB Therapeutics team took part in key events where pharmaceutical innovation was at the heart of the discussions.
MB Therapeutics raises 2 million euros
MB Therapeutics raises €2 million to industrialize and launch a solution for the manufacturing of personalized medicines in pharmacies.
MB Therapeutics celebrates its firts anniversary!
A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.
MB Therapeutics expands its leadership team
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
GERPAC 2024 is coming soon!
Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!
Sébastien Gallice : “It’s a great curiosity that arises about new concepts”
Find the interview of Sébastien Gallice, president of PREF and pharmacist in one of the largest preparatory pharmacies in France.
MB Therapeutics receives the French Tech Emergence Grant
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
MB Therapeutics expands its team with the arrival of Léna Lemierre, an expert in pharmaceutical 3D printing
Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.
The regional fund Créalia is providing support to MB Therapeutics
The seed fund Créalia awards an innovation grant to MB Therapeutics for the development of its personalized medicine solution.
MB Therapeutics is labeled as a deep tech company
MB Therapeutics has obtained the Deeptech label from BPI for a personalized medicine manufacturing project using 3D printing.